Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

View From German Industry: MDR At The Turning Point

Supply chain and sustainability top national priority issues

Executive Summary

Spectaris’ Marcus Kuhlmann describes Medica as a valued hub to meet member companies and host ecosystem and trade updates for the wider medtech industry. The German industry association’s medtech leader spoke to Medtech Insight during the 2022 event about the top concerns for manufacturers.

You may also be interested in...



Resilience, ‘Lessons Learned’ Must Be COVID Legacy In Germany

COVID-19 threat is abating and control measures easing, but government commitments made at height of pandemic to forearm against future health care emergencies should not be abandoned, says German Advisory Council on Health and Care and the IVD industry.

Resilience And ‘Lessons Learned’ Must Be The COVID Legacy In Germany

The COVID-19 threat is abating and control measures are easing, but government commitments made at the height of the pandemic to forearm against future health care emergencies should not be abandoned. That is the position of both the German Advisory Council on Health and Care and the IVD industry.

Crucial Council Of EU Debate On Medical Device Regulation Crisis Countdown

The Council of EU’s agenda for the critical upcoming health council meeting confirms position of EU Medical Device Regulation in day’s running, along with other key health issues.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147395

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel